FR2999915B1 - Utilisation de derives de l'acide imidocarboxylique en tant qu'agent apaisant - Google Patents
Utilisation de derives de l'acide imidocarboxylique en tant qu'agent apaisantInfo
- Publication number
- FR2999915B1 FR2999915B1 FR1262709A FR1262709A FR2999915B1 FR 2999915 B1 FR2999915 B1 FR 2999915B1 FR 1262709 A FR1262709 A FR 1262709A FR 1262709 A FR1262709 A FR 1262709A FR 2999915 B1 FR2999915 B1 FR 2999915B1
- Authority
- FR
- France
- Prior art keywords
- derivatives
- soothing agent
- imidocarboxylic acid
- imidocarboxylic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1262709A FR2999915B1 (fr) | 2012-12-21 | 2012-12-21 | Utilisation de derives de l'acide imidocarboxylique en tant qu'agent apaisant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1262709A FR2999915B1 (fr) | 2012-12-21 | 2012-12-21 | Utilisation de derives de l'acide imidocarboxylique en tant qu'agent apaisant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2999915A1 FR2999915A1 (fr) | 2014-06-27 |
| FR2999915B1 true FR2999915B1 (fr) | 2017-08-11 |
Family
ID=48289245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1262709A Expired - Fee Related FR2999915B1 (fr) | 2012-12-21 | 2012-12-21 | Utilisation de derives de l'acide imidocarboxylique en tant qu'agent apaisant |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2999915B1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698579A (en) * | 1993-07-02 | 1997-12-16 | Celgene Corporation | Cyclic amides |
| CA2560523C (fr) * | 1996-07-24 | 2011-09-20 | Celgene Corporation | 2-(2,6-dioxopiperidin-3-yl)-phtalimides et 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines substitues et methode pour reduire les niveaux de tnf.alpha |
| WO2012076345A1 (fr) * | 2010-12-06 | 2012-06-14 | L'oreal | Composition cosmétique comprenant un acide imidoperoxycarboxylique, un acide imidocarboxylique et un copolymère d'acide 2-acrylamido-2-méthyl- propanesulfonique |
| FR2973232B1 (fr) * | 2011-03-31 | 2014-08-15 | Oreal | Association d'acide salicylique et d'un derive d'acide imido-peroxycarboxylique en tant qu'agent apaisant |
-
2012
- 2012-12-21 FR FR1262709A patent/FR2999915B1/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2999915A1 (fr) | 2014-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2915557A4 (fr) | Micro-aiguille d'acide rétinoïque | |
| EP2971161A4 (fr) | Purification d'acide ribonucléique | |
| EP2931730A4 (fr) | Dérivés 4-pyridinonetriazines en tant qu'inhibiteurs de l'intégrase du vih | |
| EP2890691A4 (fr) | Dérivés de benzimidazole en tant qu'inhibiteurs d'itk | |
| EP2863914A4 (fr) | Dérivés de pyrazolyle en tant qu'inhibiteurs de syk | |
| EP2934535A4 (fr) | Pyrrolopyrimidines substituées en tant qu'inhibiteurs de hdm2 | |
| EP2909214A4 (fr) | Dérivés d'étoposide | |
| EP2892550A4 (fr) | Formulations aqueuses stables d'adalimumab | |
| EP2688568A4 (fr) | Cyclopropylamines en tant qu'inhibiteurs de lsd1 | |
| EP2706852A4 (fr) | Bipyridylaminopyridines en tant qu'inhibiteurs de syk | |
| EP2693881A4 (fr) | Analogues de n-phénylpyrimidine-2-amine substitués en tant qu'inhibiteurs de l'axl kinase | |
| EP2931284A4 (fr) | Dioxydes d'iminothiadiazine en tant qu'inhibiteurs de bace | |
| EP2900665A4 (fr) | Dérivés triazolyle en tant qu'inhibiteurs de la syk | |
| HUE036887T2 (hu) | Eljárás epesav-származékok elõállítására | |
| EP2707357A4 (fr) | Pyridylaminopyridines en tant qu'inhibiteurs de syk | |
| EP2917301A4 (fr) | Polyétheramines alkylées en tant qu'agents stabilisant l'argile | |
| EP2970086A4 (fr) | Récupération d'acide 3-hydroxypropionique | |
| EP2863913A4 (fr) | Analogues d'imidazolyle en tant qu'inhibiteurs de syk | |
| EP2871957A4 (fr) | Composés macrocycliques en tant qu'inhibiteurs de l'intégrase du vih | |
| BR112015002779A8 (pt) | processo para a preparação de derivados de ácido carboxílico de pirazol | |
| FR3013222B1 (fr) | Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur | |
| EP2916837A4 (fr) | Promédicament bipyridylaminopyridines en tant qu'inhibiteurs de syk | |
| EP2928888A4 (fr) | Pyridopyrazines substituées utilisées en tant qu'inhibiteurs de syk | |
| EP2877469A4 (fr) | Dérivés de naphthyridinedione substitués en tant qu'inhibiteurs de l'intégrase du vih | |
| EP2970325A4 (fr) | Détection d'acide lysophosphatidique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| ST | Notification of lapse |
Effective date: 20190906 |